Close

UBS Reiterates Sell Rating on Ionis Pharmaceuticals (IONS) Ahead of PKK-LRx Phase 2 Topline

Go back to UBS Reiterates Sell Rating on Ionis Pharmaceuticals (IONS) Ahead of PKK-LRx Phase 2 Topline
(NASDAQ: IONS) Delayed: 41.84 --0 (-0%)
Previous Close $41.84    52 Week High $62.68 
Open $41.84    52 Week Low $19.59 
Day High $41.84    P/E N/A 
Day Low $41.84    EPS $0.00 
Volume 207